Commercial collaborations and activities are central to our work at NIHR Cambridge Biomedical Research Centre and we are pleased to be working in partnership with The Wellcome Trust and Evelyn Trust. Their investment in, and support for, our research is enabling us to develop our understanding of women's health in order to develop new treatments. Cambridge BRC provided around £100k support to the women's health theme between 2009-2010, and this helped to lever around £1.2m further investment for our work.
We would also like to acknowledge specific support from GE (www.ge.com), one of the major international manufacturers of medical imaging equipment, which has gifted two voluson i ultrasound systems (plus 5 year service contracts). These have been used in all the research scans in the study.
The ACCI/Addenbrooke's Centre for Clinical Investigation (www.addenbrookes.org.uk) has been central to our theme's success, with all research scans taking place there. Equally, our collaboration with the Centre for Trophoblast Research (www.trophoblast.cam.ac.uk) and the Global Alliance to Prevent Prematurity and Stillbirth (www.gapps.org) have been key.
GAPPS is funded by the Bill and Melinda Gates Foundation and our mission reflects its mission is to lead a collaborative, global effort to increase awareness and accelerate innovative research and interventions that will improve maternal, newborn and child health outcomes. We are working with GAPPS to establish an international database of comparable prospective collections of pregnancy data and samples to facilitate translational research.
The Wellcome Trust supports research into all aspects of biomedical science from molecules and cells vital to life, through the spread of diseases or the vectors of disease across the globe, to clinical and public health research to improve the quality of healthcare.
The Evelyn Trust is a grant making charity, supporting medical research and healthcare in Cambridge, England, and the surrounding area